According to a newly published market research report by 24LifeSciences, global Graft Versus Host Disease (GVHD) Treatment market was valued at USD 1.2 billion in 2024 and is projected to reach USD 2.1 billion by 2031, growing at a compound annual growth rate (CAGR) of 8.5% during the forecast period 20252031.
Graft versus Host Disease, a serious complication following stem cell or bone...
Russian 
English
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Romaian
Portuguese (Brazil)
Tiếng Việt